Adjuvanted Influenza Vaccine: A Viewpoint by R. Baltussen

ISSN： 1173-8804

Source： BioDrugs, Vol.14, Iss.1, 2000-07, pp. : 70-71

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adjuvanted Influenza Vaccine

By Dooley M. Goa K.L.

BioDrugs, Vol. 14, Iss. 1, 2000-07 ,pp. : 61-69

Adis International

Access to resources Recommend Favorite

Liposomal Influenza Vaccine: A Viewpoint by John S. Oxford

By Oxford J.S.

BioDrugs, Vol. 11, Iss. 2, 1999-02 ,pp. : 145-146

Adis International

Access to resources Recommend Favorite

Prepandemic Influenza Vaccine H5N1 (Split Virion, Inactivated, Adjuvanted) [Prepandrix™]: A Review of its Use as an Active Immunization Against Influenza A Subtype H5N1 Virus

By Carter Natalie J. Plosker Greg L.

BioDrugs, Vol. 22, Iss. 5, 2008-01 ,pp. : 279-292

Adis International

Access to resources Recommend Favorite

Liposomal Influenza Vaccine

By Holm K.J. Goa K.L.

BioDrugs, Vol. 11, Iss. 2, 1999-02 ,pp. : 137-144

Adis International

Access to resources Recommend Favorite

Development of an AS04-Adjuvanted HPV Vaccine with the Adjuvant System Approach

By Garçon Nathalie Morel Sandra Didierlaurent Arnaud Descamps Dominique Wettendorff Martine >

BioDrugs, Vol. 25, Iss. 4, 2011-08 ,pp. : 217-226

Adis International

Access to resources Recommend Favorite